Study probes hidden effects of Pre-Surgery cancer therapy on tissue and recovery

NCT ID NCT07422974

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how chemotherapy or radiation before colorectal cancer surgery affects tiny blood vessels and scarring in skin tissue, and whether this leads to more complications. Researchers will compare 34 patients who had pre-surgery therapy with 34 who went straight to surgery. The goal is to better understand and potentially reduce surgical risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better predict and manage complications after colorectal cancer surgery, improving patient recovery.

What could go wrong

This is a small, early-stage observational study, so results may not apply to all patients. It looks at tissue samples and short-term outcomes, not long-term survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal carcinoma colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • KBC Osijek

    RECRUITING

    Osijek, 31000, Croatia

    Contact Phone: •••-•••-•••• Email: •••••@•••••